Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125340
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2023-11-04
Brief Title:
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia Short-course Therapy
Sponsor:
Jeffrey Pernica
Organization:
Hamilton Health Sciences Corporation
Study Overview
Official Title:
Optimizing Care for Children Hospitalized With Community-acquired Pneumonia a Feasibility Randomized Controlled Trial of Short-course Antibiotic Therapy
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRESTO-2
Brief Summary:
Children are commonly hospitalized because of community-acquired pneumonia CAP There are multiple high-quality randomized trials of short-course antibiotic therapy 3-5 days of treatment for adults hospitalized with CAP - but there is very little evidence in children We intend to do a pilot RCT of short-course 3-5 days vs standard-duration 8-10 days antibiotic therapy for children hospitalized for CAP
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None